65 and older and/or 18 and over and disabled
Physician participation fair market compensation
Center Management Group is currently enrolling physicians in a www.clinicaltrials.gov endorsed clinical
trial – POETRY. The
study is specific to Geriatric Medicine and will benefit participants patients and practice.
please find information regarding participation in a new pharmacogenomics
clinical registry now enrolling elderly and disabled patients available in all
50 states. A simple cheek swab test 100% covered by Medicare measures how your
patients currently metabolize hundreds of the most prescribed medications
currently available. Specialty medications for psychiatry, pain management and
cardiology as well as over-the-counter medications such as Advil, cough
medications and caffeine can be evaluated for each individual patient.
The POETRY Registry, or Pharmacogenomic
testing Of the elderly and disabled to reduce
morbidity, began in May 2014 and will be collecting data on up to
280,000 patients. The primary objective of the registry is to evaluate the
value of pharmacogenomic (PGx) testing in elderly and disabled patients. We are
collecting information to help providers better manage patient medications and
assess if testing can have a positive impact in avoiding adverse drug events –
a leading cause of accidental deaths, hospitalizations and ER
is conducted through an oral swab that is sent to the laboratory for
evaluation. A personalized test report is provided to show how a patient
metabolizes in each measured gene pathway and medications in those pathways to
help improve patient treatment plans.
market compensation will be provided to physicians for each patient
adequately enrolled in the study, $90-$100. There is no out of pocket cost
interested, we will get additional information regarding the registry and would
welcome the opportunity to speak to you about enrolling yourself and patients
the study. It’s a very simple process.